Primary cutaneous marginal zone lymphoma

From WikiMD.com - Food, Medicine & Wellness Encyclopedia


Primary cutaneous marginal zone lymphoma
Synonyms PCMZL
Pronounce N/A
Specialty N/A
Symptoms Skin lesions, Nodules, Plaques
Complications Secondary infections, Ulceration
Onset Middle age
Duration Chronic
Types N/A
Causes Unknown, possible Borrelia burgdorferi association
Risks Immunosuppression, Autoimmune disorders
Diagnosis Skin biopsy, Histopathology
Differential diagnosis Cutaneous B-cell lymphoma, Cutaneous T-cell lymphoma, Pseudolymphoma
Prevention N/A
Treatment Radiation therapy, Surgical excision, Intralesional corticosteroids
Medication N/A
Prognosis Generally Indolent with good prognosis
Frequency Rare
Deaths N/A


A type of skin lymphoma


Primary cutaneous marginal zone lymphoma (PCMZL) is a type of extranodal marginal zone B-cell lymphoma that primarily affects the skin. It is classified as a low-grade B-cell lymphoma and is part of the group of mucosa-associated lymphoid tissue (MALT) lymphomas. PCMZL is characterized by the proliferation of small B-cells, including marginal zone cells, monocytoid cells, and small lymphocytes, often with reactive germinal centers.

Clinical Presentation[edit | edit source]

PCMZL typically presents as solitary or multiple skin lesions, which may appear as red or violaceous papules, nodules, or plaques. These lesions are most commonly found on the arms, trunk, or back, but can occur anywhere on the body. The condition is generally indolent, meaning it progresses slowly and is often asymptomatic.

Pathophysiology[edit | edit source]

The exact cause of PCMZL is not well understood, but it is thought to be associated with chronic antigenic stimulation. This can be due to infections, such as Borrelia burgdorferi (the bacterium responsible for Lyme disease), or autoimmune conditions. The lymphoma cells in PCMZL are typically CD20 positive and may express other B-cell markers such as CD79a and Bcl-2, but they are usually negative for CD5, CD10, and cyclin D1.

Diagnosis[edit | edit source]

Diagnosis of PCMZL is based on clinical examination, histopathological analysis, and immunohistochemical staining of a skin biopsy. The biopsy typically shows a dense infiltrate of small B-cells in the dermis, often with reactive germinal centers. Molecular studies may reveal clonal immunoglobulin gene rearrangements, supporting the diagnosis of a B-cell lymphoma.

Treatment[edit | edit source]

Treatment options for PCMZL depend on the extent and location of the disease. Localized lesions may be treated with surgical excision or radiation therapy. In cases with multiple lesions or more extensive disease, systemic therapies such as rituximab (an anti-CD20 monoclonal antibody) or low-dose chemotherapy may be considered. The prognosis for PCMZL is generally favorable, with a high rate of long-term survival.

Prognosis[edit | edit source]

PCMZL is considered an indolent lymphoma with an excellent prognosis. Most patients experience long-term survival, and the disease rarely progresses to a more aggressive form. However, recurrences are common, and ongoing monitoring is recommended.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD